Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | -1,940 | 984 | 2,030 | 1,124 | 502 |
| Cost of Goods | -4,541 | 1,850 | 2,424 | 1,045 | 716 |
| Gross Profit | 2,601 | -866 | -394 | 79 | -214 |
| Operating Expenses | 17,253 | 13,588 | 13,598 | 11,484 | 6,770 |
| Operating Income | -15,193 | -13,604 | -13,568 | -11,360 | -6,268 |
| Interest Expense | 42 | 50 | 49 | 68 | 77 |
| Other Income | -66 | -146 | 1,330 | -55 | -123 |
| Pre-tax Income | -15,301 | -13,800 | -12,287 | -11,483 | -6,468 |
| Income Tax | 97 | N/A | -1,794 | -7,564 | -159 |
| Net Income Continuous | -15,398 | -13,800 | -10,493 | -3,919 | -6,309 |
| Net Income | $-35,885 | $-13,800 | $-10,493 | $-3,919 | $-6,309 |
| EPS Basic Total Ops | -8.00 | -3.00 | -2.40 | -1.00 | -1.80 |
| EPS Basic Continuous Ops | -3.49 | -3.02 | -2.34 | -0.95 | -1.84 |
| EPS Diluted Total Ops | -8.00 | -3.00 | -2.40 | -1.00 | -1.80 |
| EPS Diluted Continuous Ops | -3.49 | -3.02 | -2.34 | -0.95 | -1.84 |
| EBITDA(a) | $-13,931 | $-12,346 | $-12,274 | $-10,913 | $-6,977 |